Posted in | News | Lighting | Medical Optics

LCA Invests $4 Million in Lighting Technology

Low Carbon Accelerator Limited has made an investment of $1.6 illion (approx £800,000) in Lumenergi Inc. for a 14.39% equity stake. The Company has committed to invest a further $2.4 million (approx £1.2 million) subject to the achievement of certain performance milestones. The follow-on commitment will bring LCA's total equity stake in the business to 24.07%.

The investment and commitment forms part of an overall $7.5 million funding round split into two tranches, one of $3 million and a further commitment of $4.5 million subject to the milestones. Noventi, a US venture capital firm specialising in clean technology is investing alongside LCA.

Lumenergi will use the proceeds to develop its sales and marketing strategy and focus on business development. The majority of Lumenergi's resources have, to date, been invested in product development, however, the business emphasis has now shifted to the sales and marketing of the end products to realise the next stage of the company's development.

Lumenergi develops and sells energy-efficient lighting technology. The technology, which can be used in all buildings, such as offices, hospitals and schools, enables users to reduce energy consumption by dimming fluorescent lights at the brightest times of the day. The applications are Dimming Electronic Ballasts ("DEB") for fluorescent lights, and a Lighting Management Control System ("LMCS"), a lighting control software package.

The applications can be fitted to existing fluorescent lights, immediately reducing energy costs. By cutting energy consumption at peak times, they allow users to benefit from new Demand Response schemes electricity companies are introducing to better manage the grid. In the US, and increasingly in the UK, energy providers are offering financial incentives to encourage consumers to reduce their power consumption at critical times.

It is estimated that the applications will reduce energy costs from lighting by up to 70%. Lumenergi's DEBs are expected to be considerably cheaper than current DEBs on the market, with a payback time of approximately two years.

Lighting accounts for approximately 23% of all electricity consumption in the US and industrial areas around the globe. Most high rise buildings consume over 50% of their energy in lighting. Federal and state mandates and incentives are placing new demands on both consumers and suppliers of electrical power. Improvements in technologies for efficient power use, which include Lumenergi's intelligent lighting controls, will help companies comply with new regulations, and take advantage of market incentives.

Mark Shorrock, CEO of Low Carbon Investors, LCA's investment manager, said: "This is a technology which can be implemented immediately, with no changes to existing infrastructure. Lumenergi's initial target is the US where there is a huge market opportunity for its technology across government and state buildings as well as commercial real estate buildings. This, coupled with a plethora of existing rebates around Demand Response in the US, should see sales increase significantly over the next three to five years."

Bill Alling, Founder and CEO of Lumenergi said: "We welcome this injection of capital from Low Carbon Accelerator. This investment will be used to develop our sales and marketing strategy and focus on business development."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.